Cargando…
RLC phosphorylation amplifies Ca(2+) sensitivity of force in myocardium from cMyBP-C knockout mice
Hypertrophic cardiomyopathy (HCM) is the leading genetic cause of heart disease. The heart comprises several proteins that work together to properly facilitate force production and pump blood throughout the body. Cardiac myosin binding protein-C (cMyBP-C) is a thick-filament protein, and mutations i...
Autores principales: | Turner, Kyrah L., Morris, Haley S., Awinda, Peter O., Fitzsimons, Daniel P., Tanner, Bertrand C.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930131/ https://www.ncbi.nlm.nih.gov/pubmed/36715675 http://dx.doi.org/10.1085/jgp.202213250 |
Ejemplares similares
-
cMyBP-C phosphorylation modulates the time-dependent slowing of unloaded shortening in murine skinned myocardium
por: Giles, Jasmine, et al.
Publicado: (2021) -
Circulating S‐Glutathionylated cMyBP‐C as a Biomarker for Cardiac Diastolic Dysfunction
por: Zhou, Xiaoxu, et al.
Publicado: (2022) -
Molecular Modeling of Disease Causing Mutations in Domain C1 of cMyBP-C
por: Gajendrarao, Poornima, et al.
Publicado: (2013) -
Myocardial Infarction-induced N-terminal Fragment of Cardiac Myosin-binding Protein C (cMyBP-C) Impairs Myofilament Function in Human Myocardium
por: Witayavanitkul, Namthip, et al.
Publicado: (2014) -
cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca(2+)-handling abnormalities
por: De Lange, Willem J., et al.
Publicado: (2023)